Glycaemic control in type 2 diabetes

Glycaemic control in type 2 diabetes

ID:40896762

大?。?26.93 KB

頁(yè)數(shù):18頁(yè)

時(shí)間:2019-08-10

Glycaemic control in type 2 diabetes_第1頁(yè)
Glycaemic control in type 2 diabetes_第2頁(yè)
Glycaemic control in type 2 diabetes_第3頁(yè)
Glycaemic control in type 2 diabetes_第4頁(yè)
Glycaemic control in type 2 diabetes_第5頁(yè)
資源描述:

《Glycaemic control in type 2 diabetes》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫(kù)

1、main/0609_new17/11/06DiabetesGlycaemiccontrolintype2diabetesSearchdateJune2005AmaryllisCampbellQUESTIONSWhataretheeffectsofinterventionsinadultswithtype2diabetes?................3INTERVENTIONSINTERVENTIONSINADULTSInsulindeliveredbycontinuoussubcutaneousBeneficialinfusion......................14Met

2、formin(comparedwithdietaloneorplacebo).......................3UnlikelytobebeneficialSulphonylureas(reduceHbA1ccomparedInsulincomparedwithsulphonylureasaswithplaceboordietalone;newerinitialtreatment(noaddedbenefitandwithsulphonylureasreducehypoglycaemiamorehypoglycaemicepisodesandmorecomparedwithol

3、dersulphonylureas)...5weightgain)....................14LikelytobebeneficialTobecoveredinfutureupdatesEducation(comparedwithusualcare).....7AcarboseIntensivetreatmentprogrammes(comparedInsulinplusoralhypoglycaemicdrugswithusualcare)..................9ThiazolidinedionesMeglitinides(nateglinide,repag

4、linide)....10CoveredelsewhereinClinicalEvidenceTradeoffbetweenbenefitsandharmsGlycaemiccontrolintype1diabetes,p01Combinedoraldrugtreatment(comparedPreventionofcardiovasculareventsinwithmonotherapy)...............11diabetes,p01Insulin(comparedwithcontinuationoforaldrugtreatmentwhereHbA1cisSeeglossa

5、ryinadequatelycontrolled)...........14UnknowneffectivenessDifferentfrequenciesofselfbloodglucosemonitoring.....................16KeyMessages?Diabetesmellitusisnowseenasaprogressivedisorderofglucosemetabolism,affectingabout5%ofthepopulationworldwide,over85%ofwhomhavetype2diabetes.Type2diabetesmayo

6、ccurwithobesity,hypertensionanddyslipidaemia(themetabolicsyndrome),whicharepowerfulpredictorsofcardiovasculardisease.Bloodglucoselevelsriseprogressivelyovertimeinpeoplewithtype2diabetesregardlessoftreatment,causingmicrovascularandmacrovascularcomplications.?Mostpeoplewithtype2diabeteswilleventuall

7、yneedtreatmentwithoralhypoglycaemicagents.Metforminreducesglycatedhaemoglobinby1?2%,reducesmortalitycomparedwithdietalone,anddoesnotaffectweight,butcancausehypoglycaemia.SulphonylureasreduceHbA1ccomparedwithdieta

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動(dòng)畫的文件,查看預(yù)覽時(shí)可能會(huì)顯示錯(cuò)亂或異常,文件下載后無(wú)此問(wèn)題,請(qǐng)放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫(kù)負(fù)責(zé)整理代發(fā)布。如果您對(duì)本文檔版權(quán)有爭(zhēng)議請(qǐng)及時(shí)聯(lián)系客服。
3. 下載前請(qǐng)仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動(dòng)等原因無(wú)法下載或下載錯(cuò)誤,付費(fèi)完成后未能成功下載的用戶請(qǐng)聯(lián)系客服處理。